Prime Therapeutics and Pear Therapeutics Announce First Comprehensive Value-based Agreement for Prescription Digital Therapeutics reSET® and reSET-O® for the Treatment of Substance and Opioid Use Disorders
Agreement aims to reduce inpatient hospitalizations and total cost of care BOSTON & EAGAN, Minn.–(BUSINESS